News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lundbeck Inc. (formerly Ovation Pharmaceuticals) CFO: Elan Pharmaceuticals (ELN) Not an Acquisition Option Now



5/13/2009 11:26:23 AM

Bookmark and Share

COPENHAGEN, May 13 (Reuters) - Danish pharmaceutical group Lundbeck (LUN.CO) would not be able to buy Irish biotech company Elan (ELN.I) in current market conditions, Lundbeck's Chief Financial Officer Anders Gotzsche said on Wednesday.


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES